Orthocell Ltd. | Balance Sheet

Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
3,467.40
4,774.10
5,181.80
5,046.30
2,910.20
Total Accounts Receivable
126.70
178.40
185.10
116.80
170.00
Inventories
151.90
150.70
134.20
88.40
53.80
Other Current Assets
305.30
82.10
58.90
33.90
94.90
Total Current Assets
4,051.30
5,185.20
5,560.00
5,285.40
3,229.00
Net Property, Plant & Equipment
286.90
306.10
289.20
357.80
341.10
Intangible Assets
799.70
1,044.80
1,264.00
1,515.70
1,659.80
Total Assets
5,137.90
6,536.10
7,113.20
7,158.90
5,229.90
Accounts Payable
710.80
628.90
648.80
891.00
1,020.30
Other Current Liabilities
3,595.20
673.20
871.30
988.50
1,412.20
Total Current Liabilities
4,306.00
1,302.10
1,520.00
1,879.60
2,432.50
Other Liabilities
755.70
850.20
708.50
566.80
425.20
Total Liabilities
5,061.70
2,152.30
2,228.60
2,446.40
2,857.70
Common Equity (Total)
4,661.00
4,383.80
4,884.60
4,712.50
2,372.20
Total Shareholders' Equity
76.20
4,383.80
4,884.60
4,712.50
2,372.20
Total Equity
76.20
4,383.80
4,884.60
4,712.50
2,372.20
Liabilities & Shareholders' Equity
5,137.90
6,536.10
7,113.20
7,158.90
5,229.90
Preferred Stock (Carrying Value)
4,737.10
-
-
-
-

About Orthocell

View Profile
Address
Building 191
Murdoch Western Australia (WA) 6150
Australia
Employees -
Website http://www.orthocell.com.au
Updated 07/08/2019
Orthocell Ltd. engages in the development and commercialization of cell therapies and related technologies. Its products include CelGro which derives collagen medical device for soft tissue repair; and Antologous Tenocyte Implantation (Ortho-ATI) for chronic, treatment resistant tendon injuries. The company was founded by Paul Anderson and Min Hao Zheng on March 21, 2006 and is headquartered in Murdoch, Australia.